Surveillance of resistance to fluconazole and voriconazole in Candida isolates from 5 hospitals in China

Chinese Journal of Infection and Chemotherapy

Volumn 7, Issue 1, 2007, Pages 14-18

  Zhu, De Mei ^a   Zhang, Ying Yuan ^a   Wang, Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Antifungal agent; Fungal susceptibility testing; Surveillance of fungal resistance

Indexed keywords

FLUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CHINA; COMPUTER PROGRAM; DIFFUSION; DRUG SENSITIVITY; FUNGUS ISOLATION; HOSPITAL; IMAGE ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 33847723426     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmorten epidemiology of invosive fungal infections at a university hospital[J]. J Infect, 1996,33(1):23-32.
2. Beck-Sague C,Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Surveillance System[J]. J Infect Dis, 1993,167(5):1247-1251.
3. Chinese source.
4. Chinese source.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Ninth Supplement to the M2-A8, M1OO-S14[S]. January 2004, NCCLS, Villanova, PA.
6. Wenzel R, Brewer TF, Butzle JP, et al. A guide to infection diseases. Boston, MA. USA, BC Decker Inc Hamiltom. London, 2002:157-159.
7. Hazen KC, Baron EJ, Colombo AL, et al. Comparison of susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evalution using disk diffusion[J]. J Clin Microbiol, 2003,41(12):5623-5632.
8. Pfaller MA, Diekema DJ, Rinaldi MG, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing[J]. J Clin Microbiol,2005,43(12):5848-5859.
9. Pfaller MA, Boyken L, Messer A, et al. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program[J]. J Clin Microbiol, 2005,43(10):5208-5213.
10. Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints[J]. J Clin Microbiol,2006,44(3):819-826.